.GAMMA.-RAR ANTAGONIST LIGAND OR .ALPHA.-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR

摘要

Use of at least one ligand chosen from an agonist ligand specific for receptors of the RAR-.alpha type. and an antagonist ligand specific for RAR-.gamma receptors. in the preparation of a pharmaceutical composition intended to decrease the rate of apoptosis in at least one cell population. This composition can be used in particular to treat a disease or a disorder linked to an excess of the apoptosis rate in at least one cell population.